Pinto MM - Search Results

1

Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2.

Gomes AS, Correia A, Rahikkala A, Mäkilä E, Pinto MM, Sousa E, Salonen J, Saraiva L, Santos HA. Gomes AS, et al. Among authors: pinto mm. Int J Pharm. 2022 Aug 25;624:121959. doi: 10.1016/j.ijpharm.2022.121959. Epub 2022 Jul 2. Int J Pharm. 2022. PMID: 35792422 Free article.

2

Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives.

Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Gonçalves J. Saraiva L, et al. Bioorg Med Chem. 2002 Oct;10(10):3219-27. doi: 10.1016/s0968-0896(02)00169-4. Bioorg Med Chem. 2002. PMID: 12150867

3

Inhibition of protein kinase C by synthetic xanthone derivatives.

Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Gonçalves J. Saraiva L, et al. Bioorg Med Chem. 2003 Apr 3;11(7):1215-25. doi: 10.1016/s0968-0896(02)00641-7. Bioorg Med Chem. 2003. PMID: 12628649

4

Inhibition of alpha, betaI, delta, eta, and zeta protein kinase C isoforms by xanthonolignoids.

Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Gonçalves J. Saraiva L, et al. J Enzyme Inhib Med Chem. 2003 Aug;18(4):357-70. doi: 10.1080/147563601000118400. J Enzyme Inhib Med Chem. 2003. PMID: 14567551 Free article.

5

Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.

Sousa E, Paiva A, Nazareth N, Gales L, Damas AM, Nascimento MS, Pinto M. Sousa E, et al. Eur J Med Chem. 2009 Sep;44(9):3830-5. doi: 10.1016/j.ejmech.2009.04.011. Epub 2009 Apr 14. Eur J Med Chem. 2009. PMID: 19428155

6

Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone.

Palmeira A, Paiva A, Sousa E, Seca H, Almeida GM, Lima RT, Fernandes MX, Pinto M, Vasconcelos MH. Palmeira A, et al. Chem Biol Drug Des. 2010 Jul;76(1):43-58. doi: 10.1111/j.1747-0285.2010.00978.x. Epub 2010 May 4. Chem Biol Drug Des. 2010. PMID: 20456373

7

New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors.

Palmeira A, Rodrigues F, Sousa E, Pinto M, Vasconcelos MH, Fernandes MX. Palmeira A, et al. Chem Biol Drug Des. 2011 Jul;78(1):57-72. doi: 10.1111/j.1747-0285.2011.01089.x. Epub 2011 Mar 29. Chem Biol Drug Des. 2011. PMID: 21235729

8

Antifungal activity of xanthones: evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography.

Pinto E, Afonso C, Duarte S, Vale-Silva L, Costa E, Sousa E, Pinto M. Pinto E, et al. Chem Biol Drug Des. 2011 Mar;77(3):212-22. doi: 10.1111/j.1747-0285.2010.01072.x. Epub 2011 Jan 19. Chem Biol Drug Des. 2011. PMID: 21244637

9

Dual inhibitors of P-glycoprotein and tumor cell growth: (re)discovering thioxanthones.

Palmeira A, Vasconcelos MH, Paiva A, Fernandes MX, Pinto M, Sousa E. Palmeira A, et al. Biochem Pharmacol. 2012 Jan 1;83(1):57-68. doi: 10.1016/j.bcp.2011.10.004. Epub 2011 Oct 22. Biochem Pharmacol. 2012. PMID: 22044878

10

Multidrug resistance reversal effects of aminated thioxanthones and interaction with cytochrome P450 3A4.

Palmeira A, Sousa E, Fernandes MX, Pinto MM, Vasconcelos MH. Palmeira A, et al. Among authors: pinto mm. J Pharm Pharm Sci. 2012;15(1):31-45. doi: 10.18433/j3bg65. J Pharm Pharm Sci. 2012. PMID: 22365086 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters